Barton criticizes CMS's reimbursement strategy for biosimilars.
02/03/2016
https://congress.gov...
If it is actually accepted, we will actually get to see what the science is behind the support for the regulation.
There's a saying that a lot of us use quite a bit. It's called no good deed goes unpunished.
But I also think I speak for the majority and the minority that we hope that this is something that can move reasonably ...
I don't want to speak for the Department of Energy, but the draft legislation allows, without going through the appropri...